🔎 Trials Near Me

홈 › 전이성 암 › 인디애나

인디애나의 전이성 암 임상 시험

전이성 암 관련 연구 25개가 인디애나 내 여러 지역에서 참여자를 모집하고 있습니다.

인디애나의 도시

공식 연구 텍스트(영어)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • UChicago Medicine Northwest Indiana, Crown Point
  • Woodland Cancer Care Center, Michigan City
피험자 모집 중2상
전 연령 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT05564377

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  • Franciscan Health, Indianapolis
  • Franciscan Health Mooresville, Mooresville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07222800

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  • Community Health Network, Inc, Indianapolis
  • Community Health Network, Inc., Indianapolis
  • Community Health Network, Inc., Indianapolis
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07222566

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Community Health Network, Indianapolis
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06128551

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  • Parkview Research Center at Parkview Regional Medical Center, Fort Wayne
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
  • Franciscan Health, Indianapolis
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • Indiana University Health University Hospital, Indianapolis
  • Deaconess GI Specialty Center, Newburgh
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07174336

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
  • Franciscan Health, Indianapolis
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07213804

AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors

  • Community Health Network MD Anderson Cancer Center - North, Indianapolis
피험자 모집 중1상
18세 ~ 99세 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT07403721

Prospective Validation of a Points Score System Predicting 30-day Survival

  • IU Health West, Avon
  • IU Health North / Schwarz Cancer Center, Carmel
  • Methodist Hospital, Indianapolis
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT05100342

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

  • Indiana University Simon Comprehensive Cancer Center, Indianapolis
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06625775

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Parkview Research Center at Parkview Regional Medical Center, Fort Wayne
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
  • Franciscan Health, Indianapolis
  • 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT06119581

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • IU Simon Cancer Center, Indianapolis
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT06465069

A Study of IDP-001 in Advanced or Metastatic Solid Tumors

  • Community Cancer Center North, Indianapolis
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT07602842

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

  • Northwest Cancer Center, Dyer
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT06072612

A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

  • Research Site, Fort Wayne
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT07205822

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

  • Indiana University (IU) Melvin and Bren Simon Cancer Center, Indianapolis
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT05614739

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  • Community Health Network, Indianapolis
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 7. 30. 업데이트됨 · NCT04657068

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

  • Research Site, Fort Wayne
  • Research Site, Indianapolis
피험자 모집 중3상
18세 이상 · 여성 · 2026. 7. 29. 업데이트됨 · NCT07044336

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

  • Parkview Packnett Family Cancer Institute, Fort Wayne
  • Franciscan Health Indianapolis, Indianapolis
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 6. 25. 업데이트됨 · NCT06216301

A Study of LY4175408 in Participants With Advanced Cancer

  • Community Health Network, Indianapolis
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 23. 업데이트됨 · NCT07046923

Evaluating Disparities in Precision Oncology

  • Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 6. 16. 업데이트됨 · NCT06081517

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

  • Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
피험자 모집 중2/3상
18세 이상 · 남성 · 2026. 4. 8. 업데이트됨 · NCT04787744

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

  • Fort Wayne Medical Oncology and Hematology, Fort Wayne
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 4. 1. 업데이트됨 · NCT05735080

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

  • Northwest Cancer Centers, Dyer
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 3. 18. 업데이트됨 · NCT06244771

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

  • First Urology, Jeffersonville
피험자 모집 중1상
18세 이상 · 남성 · 2026. 2. 4. 업데이트됨 · NCT04729114

ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.